Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2002;106:1493-1499
Published online before print September 9, 2002, doi: 10.1161/01.CIR.0000029747.53262.5C
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
106/12/1493    most recent
01.CIR.0000029747.53262.5Cv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Karle, C. A.
Right arrow Articles by Kiehn, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Karle, C. A.
Right arrow Articles by Kiehn, J.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*12-O-TETRADECANOYLPHORBOL-13-ACETATE
Related Collections
Right arrow Arrhythmias, clinical electrophysiology, drugs

(Circulation. 2002;106:1493.)
© 2002 American Heart Association, Inc.


Clinical Investigation and Reports

Human Cardiac Inwardly-Rectifying K+ Channel Kir2.1b Is Inhibited by Direct Protein Kinase C-Dependent Regulation in Human Isolated Cardiomyocytes and in an Expression System

Christoph A. Karle, MD; Edgar Zitron, BSc; Wei Zhang, MD; Gunnar Wendt-Nordahl, BSc; Sven Kathöfer, MD; Dierk Thomas, MD; Bernd Gut, BSc; Eberhard Scholz, BSc; Christian-Friedrich Vahl, MD; Hugo A. Katus, MD; Johann Kiehn, MD

From the Department of Cardiology (C.A.K., E.Z., W.Z., G.W.-N., S.K., D.T., B.G., E.S., H.A.K., J.K.) and the Department of Cardiac Surgery (C.-F.V.), University of Heidelberg Medical School, Heidelberg, Germany.

Correspondence to Johann Kiehn, MD, Department of Cardiology, University of Heidelberg Medical School, Bergheimerstraße 58, D-69115 Heidelberg, Germany. E-mail johann_kiehn{at}med.uni-heidelberg.de

Background— Protein kinases A (PKA) and C (PKC) are activated in ischemic preconditioning and heart failure, conditions in which patients develop arrhythmias. The native inward rectifier potassium current (IK1) plays a central role in the stabilization of the resting membrane potential and the process of arrhythmogenesis. This study investigates the functional relationship between PKC and IK1.

Methods and Results— In whole-cell patch-clamp experiments with isolated human atrial cardiomyocytes, the IK1 was reduced by 41% when the nonspecific activator of PKC phorbol 12 myristate 13-acetate (PMA; 100 nmol/L) was applied. To investigate the effects of PKC on cloned channel underlying parts of the native IK1, we expressed Kir2.1b heterologously in Xenopus oocytes and measured currents with the double-electrode voltage-clamp technique. PMA decreased the current by an average of 68%, with an IC50 of 0.68 nmol/L. The inactive compound 4-{alpha}-PMA was ineffective. Thymeleatoxin and 1-oleolyl-2-acetyl-sn-glycerol, 2 specific activators of PKC, produced effects similar to those of PMA. Inhibitors of PKC, ie, staurosporine and chelerytrine, could inhibit the PMA effect (1 nmol/L) significantly. After mutation of the PKC phosphorylation sites (especially S64A and T353A), PMA became ineffective.

Conclusions— The human IK1 in atrial cardiomyocytes and one of its underlying ion channels, the Kir2.1b channel, is inhibited by PKC-dependent signal transduction pathways, possibly contributing to arrhythmogenesis in patients with structural heart disease in which PKC is activated.


Key Words: ion channels • signal transduction • arrhythmia • electrophysiology




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
W. Zhang, E. Zitron, M. Homme, L. Kihm, C. Morath, D. Scherer, S. Hegge, D. Thomas, C. P. Schmitt, M. Zeier, et al.
Aquaporin-1 Channel Function Is Positively Regulated by Protein Kinase C
J. Biol. Chem., July 20, 2007; 282(29): 20933 - 20940.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
N. Voigt, A. Friedrich, M. Bock, E. Wettwer, T. Christ, M. Knaut, R. H. Strasser, U. Ravens, and D. Dobrev
Differential phosphorylation-dependent regulation of constitutively active and muscarinic receptor-activated IK,ACh channels in patients with chronic atrial fibrillation
Cardiovasc Res, June 1, 2007; 74(3): 426 - 437.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. Dobrev, A. Friedrich, N. Voigt, N. Jost, E. Wettwer, T. Christ, M. Knaut, and U. Ravens
The G Protein-Gated Potassium Current IK,ACh Is Constitutively Active in Patients With Chronic Atrial Fibrillation
Circulation, December 13, 2005; 112(24): 3697 - 3706.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J. Fauconnier, A. Lacampagne, J.-M. Rauzier, G. Vassort, and S. Richard
Ca2+-dependent reduction of IK1 in rat ventricular cells: A novel paradigm for arrhythmia in heart failure?
Cardiovasc Res, November 1, 2005; 68(2): 204 - 212.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
Y. Fang, G. Schram, V. G. Romanenko, C. Shi, L. Conti, C. A. Vandenberg, P. F. Davies, S. Nattel, and I. Levitan
Functional expression of Kir2.x in human aortic endothelial cells: the dominant role of Kir2.2
Am J Physiol Cell Physiol, November 1, 2005; 289(5): C1134 - C1144.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X. Du, H. Zhang, C. Lopes, T. Mirshahi, T. Rohacs, and D. E. Logothetis
Characteristic Interactions with Phosphatidylinositol 4,5-Bisphosphate Determine Regulation of Kir Channels by Diverse Modulators
J. Biol. Chem., September 3, 2004; 279(36): 37271 - 37281.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
E. Zitron, C. Kiesecker, S. Luck, S. Kathofer, D. Thomas, V. A.W Kreye, J. Kiehn, H. A Katus, W. Schoels, and C. A Karle
Human cardiac inwardly rectifying current IKir2.2 is upregulated by activation of protein kinase A
Cardiovasc Res, August 15, 2004; 63(3): 520 - 527.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J. Tamargo, R. Caballero, R. Gomez, C. Valenzuela, and E. Delpon
Pharmacology of cardiac potassium channels
Cardiovasc Res, April 1, 2004; 62(1): 9 - 33.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
D. Thomas, W. Zhang, K. Wu, A.-B. Wimmer, B. Gut, G. Wendt-Nordahl, S. Kathofer, V. A.W. Kreye, H. A. Katus, W. Schoels, et al.
Regulation of HERG potassium channel activation by protein kinase C independent of direct phosphorylation of the channel protein
Cardiovasc Res, July 1, 2003; 59(1): 14 - 26.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W.-Z. Zeng, X.-J. Li, D. W. Hilgemann, and C.-L. Huang
Protein Kinase C Inhibits ROMK1 Channel Activity via a Phosphatidylinositol 4,5-Bisphosphate-dependent Mechanism
J. Biol. Chem., May 2, 2003; 278(19): 16852 - 16856.
[Abstract] [Full Text] [PDF]